T. Rowe Price Investment Management
PRAX icon

T. Rowe Price Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

T. Rowe Price Investment Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.5M Sell
175,237
-101,155
-37% -$31.3M 0.04% 333
2025
Q4 		$81.5M Buy
+276,392
New +$51.5M 0.05% 282

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Investment Management's PRAX Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its Praxis Precision Medicines (PRAX) stake by 37% in Q1 2026, selling an estimated $31.3M and leaving 175,237 shares worth $56.5M. The position accounts for 0.04% of the portfolio, ranked #333.

T. Rowe Price Investment Management first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. The position peaked at $81.5M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • T. Rowe Price Investment Management held 175,237 shares of Praxis Precision Medicines worth $56.5M as of Q1 2026.
  • T. Rowe Price Investment Management sold 101,155 Praxis Precision Medicines shares in Q1 2026, an estimated $31.3M.
  • Praxis Precision Medicines made up 0.04% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #333 holding.
  • T. Rowe Price Investment Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • T. Rowe Price Investment Management's Praxis Precision Medicines position peaked at $81.5M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.